```html

Dementia (Alzheimer’s Disease) – Comprehensive Medical Guide

Overview

Dementia is an umbrella term for a group of progressive brain disorders that impair memory, thinking, behavior, and the ability to perform everyday activities. Alzheimer’s disease (AD) is the most common cause of dementia, accounting for 60–80 % of cases worldwide.

Who it affects: The disease primarily affects older adults, with risk sharply increasing after age 65. Approximately 1 in 9 people ≥ 65 years old has Alzheimer’s disease, and the prevalence doubles every five years after that age.

Global prevalence: According to the World Health Organization (2023), more than 55 million people live with dementia worldwide; Alzheimer’s accounts for roughly 35 million of those cases. In the United States, the Alzheimer’s Association reports >6 million Americans are living with AD, and the number is projected to rise to 12.7 million by 2050.

Symptoms

Symptoms evolve gradually and can be grouped into cognitive, functional, and neuropsychiatric domains. Not all individuals experience every symptom, and severity varies.

Cognitive Symptoms

• Memory loss: Difficulty recalling recent events, conversations, or where objects were placed.
• Language problems: Trouble finding the right words (anomia) or following a conversation.
• Disorientation: Confusion about time, date, or location.
• Impaired judgment: Poor decision‑making, especially with finances or safety.
• Executive dysfunction: Difficulty planning, organizing, or completing multi‑step tasks.

Functional Symptoms

• Loss of ability to perform familiar activities such as cooking, dressing, or driving.
• Difficulty using appliances, handling money, or managing medication schedules.

Neuropsychiatric / Behavioral Symptoms

• Depression & anxiety: Persistent sadness, loss of interest, or excessive worry.
• Agitation & aggression: Restlessness, irritability, or physical outbursts.
• Hallucinations & delusions: Seeing or hearing things that aren’t there; false beliefs (e.g., “someone is stealing my money”).
• Sleep disturbances: Insomnia, daytime napping, or sundowning (increased confusion in late afternoon/evening).
• Wandering: Aimless walking, often leading to getting lost.

Causes and Risk Factors

Alzheimer’s disease is multifactorial—both genetic and environmental factors interact to trigger the pathological cascade.

Primary Pathological Features

• Amyloid‑β plaques: Sticky protein fragments that accumulate between neurons, disrupting communication.
• Neurofibrillary tangles: Twisted bundles of tau protein inside neurons, leading to cell death.
• Neuroinflammation: Chronic activation of brain immune cells (microglia) that further damages neurons.

Genetic Risk

• APOE‑ε4 allele: Carrying one copy raises risk 3‑4‑fold; two copies increase risk up to 12‑fold (NIH, 2022).
• Early‑onset familial AD: Mutations in APP, PSEN1, PSEN2 genes cause disease before age 65, but represent <1 % of all cases.

Non‑Genetic Risk Factors

• Age ≥ 65 (risk doubles every 5 years).
• Female sex (≈ 2/3 of AD patients are women) – partly due to longer life expectancy.
• Cardiovascular disease, hypertension, hyperlipidemia, and diabetes.
• Traumatic brain injury (moderate‑severe) and chronic exposure to air pollutants.
• Lifestyle factors: sedentary behavior, poor diet, smoking, and excessive alcohol use.
• Low educational attainment and limited cognitive reserve.

Diagnosis

There is no single test that definitively diagnoses Alzheimer’s disease. Diagnosis is a comprehensive process that combines clinical assessment, laboratory testing, and neuroimaging.

Step‑by‑Step Approach

1. Medical history & physical exam: Review of symptom onset, progression, family history, and medication list.
2. Cognitive screening tools:
   • Mini‑Mental State Examination (MMSE)
   • Montreal Cognitive Assessment (MoCA) – more sensitive for early disease.
3. Functional assessment: Activities of Daily Living (ADL) questionnaires (e.g., Lawton‑Brody scale).
4. Laboratory tests: CBC, CMP, thyroid‑stimulating hormone, vitamin B12, and syphilis serology to rule out reversible causes.
5. Neuroimaging:
   • MRI – evaluates atrophy pattern (medial temporal lobe) and excludes stroke, tumor.
   • CT – used when MRI unavailable.
   • FDG‑PET – shows reduced glucose metabolism in posterior cingulate/temporal cortex.
   • Amyloid PET or CSF analysis (Aβ42, total tau, phosphorylated tau) can confirm amyloid pathology per 2023 NIA‑AA criteria.
6. Neuropsychological testing (optional): Detailed assessment of memory, language, visuospatial skills, and executive function.

Diagnostic Criteria

The 2023 National Institute on Aging–Alzheimer’s Association (NIA‑AA) framework classifies AD into:

• Pre‑clinical (biomarker‑positive, no symptoms)
• Mild Cognitive Impairment due to AD
• Alzheimer’s dementia (mild, moderate, severe)

Treatment Options

Current therapies aim to slow symptom progression, manage behavioral problems, and improve quality of life. No cure exists, but several FDA‑approved drugs and non‑pharmacologic interventions are available.

Pharmacologic Therapies

• Cholinesterase inhibitors: Donepezil, rivastigmine, galantamine – modestly improve cognition and daily functioning in mild‑to‑moderate AD.<sup>[Mayo Clinic 2024]</sup>
• NMDA‑receptor antagonist: Memantine – used for moderate‑to‑severe disease; may be combined with a cholinesterase inhibitor.
• Disease‑modifying agents (under investigation):
  • Lecanemab (Leqembi) – monoclonal antibody targeting amyloid‑β; FDA granted accelerated approval in 2023 for early AD. Shows ~27 % slowing of cognitive decline.<sup>[FDA 2023]</sup>
  • Donanemab – similar mechanism, pending approval (clinical trials show ~35 % slowing).
• Behavioral symptom meds (used sparingly): SSRIs for depression/anxiety, low‑dose antipsychotics (e.g., risperidone) for severe agitation, but carry risk of stroke and mortality in elderly.

Non‑Pharmacologic Interventions

• Cognitive stimulation therapy (CST): Structured group activities that improve cognition and mood.
• Physical exercise: 150 min/week of moderate aerobic activity reduces decline (Cleveland Clinic, 2022).
• Dietary approaches: Mediterranean or MIND diet rich in leafy greens, berries, fish, nuts, and olive oil.
• Sleep hygiene: Consistent schedule, limiting caffeine, treating obstructive sleep apnea.
• Social engagement: Maintaining friendships, volunteering, or participating in community groups.

Procedural/Supportive Options

• Occupational therapy – adapts home environment, teaches compensatory strategies.
• Speech‑language therapy – for language breakdown.
• Advance care planning – legal documentation of preferences for future medical care.

Living with Dementia (Alzheimer’s disease)

Managing daily life requires a team approach that includes the person with AD, family, caregivers, and health professionals.

Practical Tips for Patients and Caregivers

• Create routines: Consistent meal, medication, and bedtime schedules reduce confusion.
• Label cabinets & drawers: Pictures and words help locate items.
• Use calendars and reminder apps: Visual day planners or voice‑assistant prompts.
• Simplify tasks: Break complex activities into single steps (“first put on socks, then shoes”).
• Safety modifications: Install grab bars, remove loose rugs, consider a medical alert bracelet.
• Stay hydrated & eat balanced meals: Dehydration can worsen cognition.
• Engage in enjoyable activities: Music, gardening, or art stimulate preserved abilities.
• Caregiver self‑care: Take regular breaks, join support groups, and seek respite services.

Legal & Financial Planning

Early in the disease, arrange power of attorney, durable health care proxy, and update wills. Consult geriatric legal specialists to protect assets and ensure wishes are honored.

Prevention

While age‑related risk cannot be eliminated, evidence supports several modifiable factors that can lower the likelihood of developing Alzheimer’s.

Evidence‑Based Strategies

• Physical activity: At least 30 minutes of moderate exercise most days (WHO, 2022).
• Heart‑healthy diet: Mediterranean, DASH, or MIND diets associated with 30‑50 % reduced risk.
• Cognitive engagement: Lifelong learning, puzzles, bilingualism, or musical training build cognitive reserve.
• Social interaction: Regular contact with friends/family lowers risk of cognitive decline.
• Control vascular risk factors: Manage blood pressure, cholesterol, diabetes, and quit smoking.
• Quality sleep: 7‑9 hours/night; treat sleep apnea.
• Limit alcohol & avoid illicit drugs: Excessive alcohol (>2 drinks/day) increases neurotoxicity.
• Protect head injuries: Wear helmets, use seat belts, and manage fall risk.

Complications

If Alzheimer’s disease progresses without appropriate management, a cascade of complications can arise:

• Severe functional dependence: Inability to perform ADLs, requiring full‑time caregiving or facility placement.
• Malnutrition & dehydration: Forgetting to eat/drink, dysphagia.
• Infections: Urinary tract infections and pneumonia (often due to aspiration).
• Falls and fractures: Result from gait disturbances and spatial disorientation.
• Psychiatric comorbidities: Depression, anxiety, and psychosis.
• Legal and financial strain: Mismanagement of finances, elder abuse.
• Increased mortality: Advanced AD shortens life expectancy by 3–10 years, often due to complications listed above.

When to Seek Emergency Care

---

References: Mayo Clinic. Alzheimer’s disease treatment 2024; CDC. Dementia prevention 2023; NIH National Institute on Aging. Alzheimer’s disease facts and figures 2022; WHO. Dementia: a public health priority 2022; Cleveland Clinic. Exercise & brain health 2022; FDA. Lecanemab approval 2023; Alzheimer’s Association. 2024 Alzheimer’s Disease Facts & Figures.

```